Amy Flaxman

19.7k total citations · 1 hit paper
17 papers, 998 citations indexed

About

Amy Flaxman is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Amy Flaxman has authored 17 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Amy Flaxman's work include Antimicrobial Resistance in Staphylococcus (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Influenza Virus Research Studies (2 papers). Amy Flaxman is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Influenza Virus Research Studies (2 papers). Amy Flaxman collaborates with scholars based in United Kingdom, Sweden and Switzerland. Amy Flaxman's co-authors include Pedro M. Folegatti, Alison M. Lawrie, Angela M. Minassian, Elizabeth J. Kelly, Nisha Singh, Carina C. D. Joe, Katherine R. W. Emary, Mimi M. Hou, Natalie G. Marchevsky and Katie Ewer and has published in prestigious journals such as Scientific Reports, Biochemical Journal and Frontiers in Immunology.

In The Last Decade

Amy Flaxman

17 papers receiving 971 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

2020 817 citations Angela M. Minassian, Amy Flaxman et al. Oxford University Research Archive (ORA) (University of Oxford) profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Flaxman United Kingdom	9	783	280	151	141	116	17	998
Carina C. D. Joe United Kingdom	5	728 0.9×	280 1.0×	120 0.8×	110 0.8×	82 0.7×	9	878
Thomas A. Rawlinson United Kingdom	6	712 0.9×	278 1.0×	149 1.0×	111 0.8×	76 0.7×	8	958
Pedro M. Folegatti United Kingdom	9	834 1.1×	295 1.1×	160 1.1×	137 1.0×	176 1.5×	13	1.1k
Minnan Yang China	7	949 1.2×	302 1.1×	137 0.9×	218 1.5×	79 0.7×	8	1.2k
Mimi M. Hou United Kingdom	2	706 0.9×	277 1.0×	103 0.7×	86 0.6×	63 0.5×	6	824
Weixiao Han China	5	849 1.1×	303 1.1×	101 0.7×	108 0.8×	70 0.6×	7	988
Saied Ghorbani Iran	13	486 0.6×	160 0.6×	88 0.6×	138 1.0×	178 1.5×	49	1.0k
Freja Kirsebom United Kingdom	16	447 0.6×	190 0.7×	173 1.1×	100 0.7×	231 2.0×	32	773
Natalie G. Marchevsky United Kingdom	5	721 0.9×	278 1.0×	104 0.7×	87 0.6×	70 0.6×	16	877

Countries citing papers authored by Amy Flaxman

Since Specialization

Citations

This map shows the geographic impact of Amy Flaxman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Flaxman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Flaxman more than expected).

Fields of papers citing papers by Amy Flaxman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Flaxman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Flaxman. The network helps show where Amy Flaxman may publish in the future.

Co-authorship network of co-authors of Amy Flaxman

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Flaxman. A scholar is included among the top collaborators of Amy Flaxman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Flaxman. Amy Flaxman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Flaxman, Amy, Sarah Sebastian, Sofia Appelberg, et al.. (2024). Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse. PLoS Pathogens. 20(6). e1012262–e1012262. 8 indexed citations

Sharpe, Hannah, Nicholas M. Provine, Georgina Bowyer, et al.. (2022). CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination. JCI Insight. 7(6). 8 indexed citations

Noé, Andrés, Mehreen S. Datoo, Amy Flaxman, et al.. (2022). Deep Immune Phenotyping and Single-Cell Transcriptomics Allow Identification of Circulating TRM-Like Cells Which Correlate With Liver-Stage Immunity and Vaccine-Induced Protection From Malaria. Frontiers in Immunology. 13. 795463–795463. 13 indexed citations

Folegatti, Pedro M., Amy Flaxman, Daniel Jenkin, et al.. (2021). Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies. Vaccines. 9(3). 262–262. 4 indexed citations

Butler, Christopher, Pedro M. Folegatti, Julie Allen, et al.. (2021). Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS). Vaccines. 9(8). 851–851. 10 indexed citations

Minassian, Angela M., Amy Flaxman, Pedro M. Folegatti, et al.. (2020). Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Oxford University Research Archive (ORA) (University of Oxford). 817 indexed citations breakdown →

Sebastian, Sarah, Amy Flaxman, Marta Ulaszewska, et al.. (2020). A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector. Vaccines. 8(2). 241–241. 11 indexed citations

Noé, Andrés, Duncan Bellamy, Amy Flaxman, et al.. (2019). NOVEL METHODS TO DETERMINE LIVER-STAGE MALARIA VACCINE CORRELATES OF PROTECTION: KINETICS, DEEP IMMUNE PHENOTYPING AND TRANSCRIPTOMICS. American Journal of Tropical Medicine and Hygiene. 101. 415–415. 1 indexed citations

Folegatti, Pedro M., Duncan Bellamy, Amy Flaxman, et al.. (2019). Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line. Vaccines. 7(1). 33–33. 21 indexed citations

10.

Flaxman, Amy, Yuko Yamaguchi, Pauline M. van Diemen, et al.. (2018). Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination. Vaccine. 37(3). 494–501. 2 indexed citations

11.

Flaxman, Amy & Katie Ewer. (2018). Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man. Vaccines. 6(3). 43–43. 25 indexed citations

12.

Allen, Elizabeth, Amy Flaxman, Pauline M. van Diemen, et al.. (2018). Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease. Vaccine. 37(3). 502–509. 4 indexed citations

13.

Flaxman, Amy, Pauline M. van Diemen, Yuko Yamaguchi, et al.. (2017). Development of persistent gastrointestinal S. aureus carriage in mice. Scientific Reports. 7(1). 12415–12415. 8 indexed citations

14.

Cabral‐Miranda, Gustavo, Matthew D. Heath, Mona O. Mohsen, et al.. (2017). Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax. Vaccines. 5(2). 10–10. 30 indexed citations

15.

Flaxman, Amy, Christine S. Rollier, Matthew K. O’Shea, et al.. (2016). Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion. Vaccine. 34(15). 1792–1799. 11 indexed citations

16.

Flaxman, Amy, Elizabeth Allen, Claudia Lindemann, et al.. (2016). Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort study. BMJ Open. 6(6). e010975–e010975. 1 indexed citations

17.

Sherwood, Victoria, Amy Flaxman, Wendy N. Cooper, et al.. (2010). Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis. Biochemical Journal. 430(2). 207–213. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact